Aliri Bioanalysis Overview
- Year Founded
-
1991
- Status
-
Private
- Employees
-
116
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
3
- Investments
-
1
Aliri Bioanalysis General Information
Description
Operator of a contract research organization intended to provide molecular imaging services. The company offers spatial multi-omics services based on different bio-analytical and imaging techniques including quantitative mass spectrometry for various therapeutic areas, including cardiovascular and metabolic diseases, enabling its clients to provide better drug efficacy and toxicity evaluations from preclinical to clinical stages.
Contact Information
Website
www.aliribio.comCorporate Office
- 4720 Forge Road
- Suite 108
- Colorado Springs, CO 80907
- United States
Corporate Office
- 4720 Forge Road
- Suite 108
- Colorado Springs, CO 80907
- United States
Aliri Bioanalysis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Aliri Bioanalysis Comparisons
Industry
Financing
Details
Aliri Bioanalysis Competitors (4)
One of Aliri Bioanalysis’s 4 competitors is Voiant, a Private Equity-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Voiant | Private Equity-Backed | Boston, MA | ||||
| Alphalyse | Private Equity-Backed | Odense, Denmark | ||||
| Nova in Silico | Venture Capital-Backed | Lyon, France | ||||
| Owkin | Venture Capital-Backed | Paris, France |
Aliri Bioanalysis Patents
Aliri Bioanalysis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3125695-A1 | Method for evaluating molecular changes related to a molecule effect in a biological sample | Pending | 22-Jan-2019 | ||
| US-20220137027-A1 | Method for evaluating molecular changes related to a molecule effect in a biological sample | Pending | 22-Jan-2019 | ||
| WO-2020152151-A1 | Method for evaluating molecular changes related to a molecule effect in a biological sample | Inactive | 22-Jan-2019 | ||
| JP-2022517827-A | Methods for assessing molecular changes associated with molecular effects in biological samples | Pending | 22-Jan-2019 | ||
| JP-6860475-B2 | How to characterize a sample by mass spectrometric imaging | Active | 26-Aug-2014 | G06T7/0014 |
Aliri Bioanalysis Signals
Aliri Bioanalysis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Aliri Bioanalysis Investments (1)
Aliri Bioanalysis’s most recent deal was a Buyout/LBO with Pyxant Labs. The deal was made on 17-May-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pyxant Labs | 17-May-2021 | Buyout/LBO | Laboratory Services (Healthcare) |
Aliri Bioanalysis FAQs
-
When was Aliri Bioanalysis founded?
Aliri Bioanalysis was founded in 1991.
-
Where is Aliri Bioanalysis headquartered?
Aliri Bioanalysis is headquartered in Colorado Springs, CO.
-
What is the size of Aliri Bioanalysis?
Aliri Bioanalysis has 116 total employees.
-
What industry is Aliri Bioanalysis in?
Aliri Bioanalysis’s primary industry is BPO/Outsource Services.
-
Is Aliri Bioanalysis a private or public company?
Aliri Bioanalysis is a Private company.
-
What is Aliri Bioanalysis’s current revenue?
The current revenue for Aliri Bioanalysis is .
-
How much funding has Aliri Bioanalysis raised over time?
Aliri Bioanalysis has raised $754K.
-
Who are Aliri Bioanalysis’s investors?
ARCHIMED has invested in Aliri Bioanalysis.
-
Who are Aliri Bioanalysis’s competitors?
Voiant, Alphalyse, Nova in Silico, and Owkin are competitors of Aliri Bioanalysis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process